Scinovex
article Open AccessTop 1% cited

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Cancer Cell · 2007 · Vol. 11(1) · pp. 83–95
Tracy T. BatchelorA. Gregory SorensenEmmanuelle di TomasoWei-Ting ZhangDan G. DudaKenneth S. CohenKevin R. KozakDaniel P. CahillPoe-Jou ChenMingwang ZhuMarek AncukiewiczMaciej MrugalaScott R. PlotkinJan DrappatzDavid N. LouisPercy IvyDavid T. ScaddenThomas BennerJay S. LoefflerPatrick Y. WenRakesh K. Jain
Angiogenesis and VEGF in CancerGlioma Diagnosis and TreatmentCancer, Hypoxia, and MetabolismTyrosine-kinase inhibitorMedicineEdemaCancer researchTyrosine kinaseReceptorInternal medicineReceptor tyrosine kinaseGlioblastomaEndocrinology

MeSH terms

Brain EdemaBrain NeoplasmsEnzyme-Linked Immunosorbent AssayFibroblast Growth FactorsFlow CytometryGlioblastomaHumansImage Processing, Computer-AssistedIndolesMagnetic Resonance ImagingNeoplastic Cells, CirculatingNeoplasm Recurrence, LocalNeovascularization, PathologicQuinazolinesNeoplastic Stem Cells

Funding

  • Pfizer
  • National Institutes of Health
Citations
1,760
FWCI
73.59
field-weighted impact
References
63
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.